Endotec Group Limited 07194501 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is a dormant holding company Digita Accounts Production Advanced 6.30.9574.0 true false true 07194501 2024-01-01 2024-12-31 07194501 2024-12-31 07194501 bus:OrdinaryShareClass1 2024-12-31 07194501 core:RetainedEarningsAccumulatedLosses 2024-12-31 07194501 core:ShareCapital 2024-12-31 07194501 core:SharePremium 2024-12-31 07194501 bus:SmallEntities 2024-01-01 2024-12-31 07194501 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07194501 bus:FilletedAccounts 2024-01-01 2024-12-31 07194501 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07194501 bus:RegisteredOffice 2024-01-01 2024-12-31 07194501 bus:Director1 2024-01-01 2024-12-31 07194501 bus:Director2 2024-01-01 2024-12-31 07194501 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 07194501 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07194501 countries:England 2024-01-01 2024-12-31 07194501 core:CostValuation 2023-12-31 07194501 2023-01-01 2023-12-31 07194501 2023-12-31 07194501 bus:OrdinaryShareClass1 2023-12-31 07194501 core:RetainedEarningsAccumulatedLosses 2023-12-31 07194501 core:ShareCapital 2023-12-31 07194501 core:SharePremium 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07194501

Endotec Group Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Endotec Group Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

Endotec Group Limited

Company Information

Directors

S J Doe

J Doe

Registered office

Unit E
Manby Hall Business Park
Immingham
DN40 2LT

 

Endotec Group Limited

(Registration number: 07194501)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Investments

4

5,160

5,160

Capital and reserves

 

Called up share capital

5

100

100

Share premium reserve

4,900

4,900

Retained earnings

160

160

Shareholders' funds

 

5,160

5,160

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the Company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 September 2025 and signed on its behalf by:
 

.........................................
S J Doe
Director

.........................................
J Doe
Director

 

Endotec Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The Company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit E
Manby Hall Business Park
Immingham
DN40 2LT

These financial statements were authorised for issue by the Board on 18 September 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. No adjustment was necessary on transition to new accounting standards.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling, the funtinal currency of the company, and are rounded to the nearest pound.

Group accounts not prepared

The company is part of a small group. The company has taken advantage of the exemption provided by Section 398 of the Companies Act 2006 and has not prepared group accounts..

Going concern
The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises of dividend income from subsidiary companies.

Investments

Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Share capital

Ordinary shares are classified as equity.

Dividends

Dividend distribution to the Company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the Company (including Directors) during the year, was 2 (2023 - 2).

 

Endotec Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Investments

2024
£

2023
£

Investments in subsidiaries

5,160

5,160

Subsidiaries

£

Cost or valuation

At 1 January 2024

5,160

Provision

Carrying amount

At 31 December 2024

5,160

At 31 December 2023

5,160

5

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100